SLC6A3 and Parkinson disease: First, from the standpoint of its locomotor benefits, our results suggest the partial blockade of DA uptake by L-DOPA that occurs paired only with DAT loss associated with PD symptoms, may help to extend the longevity of DA in the synapse.